Evidence map›Paper›PMID 40735412›Full record

ReviewAutism & developmental language impairments

Communicative Skills Assessment Scale: Contributions to the Validation of Autism Spectrum Disorder.

Diana Oliveira, Marisa Lousada, Daniela Figueiredo

Abstract readReview
In one paragraph

Review in Autism & developmental language impairments. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marisa LousadaUniversidade de Aveiro-ESSUA, Aveiro, Portugal.ORCID https://orcid.org/0000-0003-0326-0257
Daniela FigueiredoUniversidade de Aveiro-ESSUA, Aveiro, Portugal.ORCID https://orcid.org/0000-0002-3160-7871

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Speech-language pathologists actively participate in the assessment of pragmatics in children with Autism Spectrum Disorder (ASD). However, in Portugal, there is a shortage of valid and reliable instruments to assess this domain in detail. Therefore, it was deemed relevant to help validate the Methods: A cross-sectional, descriptive correlational study was conducted. The sample included 97 children, aged between 4 and 7 years and 11 months, diagnosed with ASD with European Portuguese as their native language. As an exclusion criterion, the co-occurrence of intellectual developmental disorder was defined. The internal consistency of the EAC was analyzed through the calculation of Cronbach's alpha and test-retest reliability through the calculation of the intraclass correlation coefficient. Convergent validity was also analyzed using Spearman's correlation coefficient. Results: The EAC presented a high internal consistency value, with a Cronbach's alpha of 0.956. The test-retest reliability analysis (n = 27) revealed good stability in the participants' responses at both assessment moments, with ICC values varying between 0.642 and 0.842. In the study of convergent validity, statistically significant correlations were observed between the EAC total score and the two scales of the Strengths and Difficulties Questionnaire-Portuguese Version (SDQ-Por): relationship problems with colleagues (r Conclusion: The EAC presents good reliability and validity for children with ASD, suggesting its adequacy as a research and clinical tool for testing pragmatics within this population. Implications: This study will improve clinical decision making regarding ASD and guide future research.

Indexed as

Autism Spectrum Disordercommunicationreliabilityscalevalidity

Identifiers

PMID40735412
PMCPMC12304631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.